Zheng X - Search Results

1

Synthesis and evaluation of curcumin-related compounds containing inden-2-one for their effects on human cancer cells.

Zhou D, Ding N, Zhao S, Li D, Van Doren J, Qian Y, Wei X, Zheng X. Zhou D, et al. Among authors: zheng x. Biol Pharm Bull. 2014;37(12):1977-81. doi: 10.1248/bpb.b14-00477. Biol Pharm Bull. 2014. PMID: 25451846 Free article.

2

Synthesis and evaluation of curcumin-related compounds for anticancer activity.

Wei X, Du ZY, Zheng X, Cui XX, Conney AH, Zhang K. Wei X, et al. Among authors: zheng x. Eur J Med Chem. 2012 Jul;53:235-45. doi: 10.1016/j.ejmech.2012.04.005. Epub 2012 Apr 16. Eur J Med Chem. 2012. PMID: 22551677

3

Effects of cyclohexanone analogues of curcumin on growth, apoptosis and NF-κB activity in PC-3 human prostate cancer cells.

Wei X, DU ZY, Cui XX, Verano M, Mo RQ, Tang ZK, Conney AH, Zheng X, Zhang K. Wei X, et al. Among authors: zheng x. Oncol Lett. 2012 Aug;4(2):279-284. doi: 10.3892/ol.2012.710. Epub 2012 May 10. Oncol Lett. 2012. PMID: 22844370 Free PMC article.

4

Synthesis and biological evaluation of unsymmetrical curcumin analogues as tyrosinase inhibitors.

Jiang Y, Du Z, Xue G, Chen Q, Lu Y, Zheng X, Conney AH, Zhang K. Jiang Y, et al. Among authors: zheng x. Molecules. 2013 Apr 3;18(4):3948-61. doi: 10.3390/molecules18043948. Molecules. 2013. PMID: 23552906 Free PMC article.

5

Effects of pyridine analogs of curcumin on growth, apoptosis and NF-κB activity in prostate cancer PC-3 cells.

Wei X, Zhou D, Wang H, Ding N, Cui XX, Wang H, Verano M, Zhang K, Conney AH, Zheng X, DU ZY. Wei X, et al. Among authors: zheng x. Anticancer Res. 2013 Apr;33(4):1343-50. Anticancer Res. 2013. PMID: 23564771

6

Anti-proliferative, anti-inflammatory and antioxidant effects of curcumin analogue A₂.

Du ZY, Wei X, Huang MT, Zheng X, Liu Y, Conney AH, Zhang K. Du ZY, et al. Among authors: zheng x. Arch Pharm Res. 2013 Oct;36(10):1204-10. doi: 10.1007/s12272-013-0216-1. Epub 2013 Jul 27. Arch Pharm Res. 2013. PMID: 23888334

7

Synthesis and evaluation of curcumin-related compounds containing benzyl piperidone for their effects on human cancer cells.

Zhou DY, Zhang K, Conney AH, Ding N, Cui XX, Wang H, Verano M, Zhao SQ, Fan YX, Zheng X, Du ZY. Zhou DY, et al. Among authors: zheng x. Chem Pharm Bull (Tokyo). 2013;61(11):1149-55. doi: 10.1248/cpb.c13-00507. Epub 2013 Aug 27. Chem Pharm Bull (Tokyo). 2013. PMID: 23985704 Free article.

8

Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.

Wang H, Cui XX, Goodin S, Ding N, Van Doren J, Du Z, Huang MT, Liu Y, Cheng X, Dipaola RS, Conney AH, Zheng X. Wang H, et al. Among authors: zheng x. Oncol Rep. 2014 Feb;31(2):835-41. doi: 10.3892/or.2013.2885. Epub 2013 Nov 29. Oncol Rep. 2014. PMID: 24296978 Free PMC article.

9

Effects of curcumin analogues for inhibiting human prostate cancer cells and the growth of human PC-3 prostate xenografts in immunodeficient mice.

Zhou DY, Ding N, Van Doren J, Wei XC, Du ZY, Conney AH, Zhang K, Zheng X. Zhou DY, et al. Among authors: zheng x. Biol Pharm Bull. 2014;37(6):1029-34. doi: 10.1248/bpb.b14-00044. Epub 2014 Mar 19. Biol Pharm Bull. 2014. PMID: 24647337 Free article.

10

A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors.

Ding N, Cui XX, Gao Z, Huang H, Wei X, Du Z, Lin Y, Shih WJ, Rabson AB, Conney AH, Hu C, Zheng X. Ding N, et al. Among authors: zheng x. Int J Oncol. 2014 Jun;44(6):2139-45. doi: 10.3892/ijo.2014.2350. Epub 2014 Mar 19. Int J Oncol. 2014. PMID: 24647860 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25,114 results

Search Page

Filters